The Food and Drug Administration (FDA) yesterday recalled 1.077 million Epilramate film-coated tablets after an inspection found that several batches of the medicine contained insufficient amounts of its main ingredient.
Two batches of Epilramate 25mg film-coated tablets (batch Nos. 190441 and 210466) and two batches of Epilramate 100mg film-coated tablets (batch Nos. 210467 and 210471) are to be withdrawn from the market, the agency said.
FDA medicinal product division specialist Hsu Chih-yu (許芷瑀) said that the main ingredient of the medicine is topiramate, which is primarily used for adjuvant treatment of partial epilepsy in adults and children over two, as well as epilepsy with Lennox-Gastaut syndrome or primary generalized tonic-clonic epilepsy.
Photo courtesy of the Food and Drug Administration
The medicine can be administered to treat people with partial-onset seizures or to prevent migraine.
“During the ongoing stability tests of the medicine, TWi Pharmaceuticals found that the amount of the main ingredient in the two types of tablets was 94 percent, below the 95 percent and 105 percent approved by FDA respectively,” Hsu said. “The impurities in the two types of tablets were 0.33 percent and 0.54 percent respectively, which also exceed the FDA standard of 0.25 percent.”
“As the medical effects might be compromised due to the errors, we have asked TWi Pharmaceuticals to recall the two types of tablets by Dec. 2,” she said.
Photo courtesy of the Food and Drug Administration
The National Health Insurance system last year covered the cost of 120,000 Epilramate 25mg tablets and 320,000 100mg tablets, its database showed.
TWi was also required to submit a report detailing the recall process as well as subsequent corrective measures, Hsu said.
Medical institutions and pharmacies across the nation should comply with the recall efforts, she said, adding that people who have taken the medicine should consult their doctors if they have doubts.
Separately, more than 80 percent of the medical institutions in the nation are expected to resume normal nuclear medicinal services this week following an emergency request to increase the domestic supply of technetium-99, the FDA said.
The global supply of technetium-99, a radioactive isotope commonly used in imaging, was disrupted by an unexpected mechanical failure of a BR2 nuclear reactor in Belgium last week. Due to a foreseeable shortage of the substance, hospitals have suspended or postponed exams in their nuclear medicinal departments.
FDA medicinal product section chief Yang Bo-wen (楊博文) said that technetium-99 is a key substance used in the imaging of the thyroid and salivary glands, as well as heterotopic gastric mucosa and tear ducts.
The government has issued permits to five suppliers to import the regulated substance. Three of the suppliers have reported supply shortages.
Yang said that it is difficult to gauge domestic demand for technetium-99, adding that the FDA has asked the importers to increase the supply of the substance.
A group of Taiwanese-American and Tibetan-American students at Harvard University on Saturday disrupted Chinese Ambassador to the US Xie Feng’s (謝鋒) speech at the school, accusing him of being responsible for numerous human rights violations. Four students — two Taiwanese Americans and two from Tibet — held up banners inside a conference hall where Xie was delivering a speech at the opening ceremony of the Harvard Kennedy School China Conference 2024. In a video clip provided by the Coalition of Students Resisting the CCP (Chinese Communist Party), Taiwanese-American Cosette Wu (吳亭樺) and Tibetan-American Tsering Yangchen are seen holding banners that together read:
UNAWARE: Many people sit for long hours every day and eat unhealthy foods, putting them at greater risk of developing one of the ‘three highs,’ an expert said More than 30 percent of adults aged 40 or older who underwent a government-funded health exam were unaware they had at least one of the “three highs” — high blood pressure, high blood lipids or high blood sugar, the Health Promotion Administration (HPA) said yesterday. Among adults aged 40 or older who said they did not have any of the “three highs” before taking the health exam, more than 30 percent were found to have at least one of them, Adult Preventive Health Examination Service data from 2022 showed. People with long-term medical conditions such as hypertension or diabetes usually do not
POLICE INVESTIGATING: A man said he quit his job as a nurse at Taipei Tzu Chi Hospital as he had been ‘disgusted’ by the behavior of his colleagues A man yesterday morning wrote online that he had witnessed nurses taking photographs and touching anesthetized patients inappropriately in Taipei Tzu Chi Hospital’s operating theaters. The man surnamed Huang (黃) wrote on the Professional Technology Temple bulletin board that during his six-month stint as a nurse at the hospital, he had seen nurses taking pictures of patients, including of their private parts, after they were anesthetized. Some nurses had also touched patients inappropriately and children were among those photographed, he said. Huang said this “disgusted” him “so much” that “he felt the need to reveal these unethical acts in the operating theater
Heat advisories were in effect for nine administrative regions yesterday afternoon as warm southwesterly winds pushed temperatures above 38°C in parts of southern Taiwan, the Central Weather Administration (CWA) said. As of 3:30pm yesterday, Tainan’s Yujing District (玉井) had recorded the day’s highest temperature of 39.7°C, though the measurement will not be included in Taiwan’s official heat records since Yujing is an automatic rather than manually operated weather station, the CWA said. Highs recorded in other areas were 38.7°C in Kaohsiung’s Neimen District (內門), 38.2°C in Chiayi City and 38.1°C in Pingtung’s Sandimen Township (三地門), CWA data showed. The spell of scorching